Absci Corporation (ABSI) Dividend History

Company News

• Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  Absci Corporation, a data-first generative AI drug creation company, announced that it granted a non-statutory stock option to a newly-hired non-executive employee as an inducement to join the company.

  GlobeNewswire Inc.
• Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

  Absci Corporation, a data-first generative AI drug creation company, announced its participation in the upcoming Guggenheim Securities SMID Cap Biotech Conference, where the company's management will be featured in a fireside chat.

  GlobeNewswire Inc.
• Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

  Absci and AMD have announced a strategic collaboration and a $20 million equity investment from AMD to accelerate AI-driven drug discovery. The partnership aims to leverage AMD's high-performance computing solutions and software to support Absci's advanced drug discovery models.

  GlobeNewswire Inc.

  Featured Companies: AMD
• AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care

  The article discusses how AI is transforming healthcare, enabling breakthroughs in diagnostics and patient care. It highlights advancements by companies like Avant Technologies, RadNet, Stryker, Absci, and Twist Bioscience in areas such as retinal scanning, radiology workflow, and therapeutic development.

  Benzinga
• 4 Biotech Stocks With AI, Machine Learning Prowess

  The article discusses four biotech companies leveraging AI and machine learning technology to improve drug discovery and development processes. These companies are Absci, Firefly Neuroscience, Korro Bio, and NeuroSense Therapeutics.

  Investing.com

  Featured Companies: AIFF KRRO NRSN